News|Articles|October 6, 2025
Optimizing Micronization and Spray-Drying to Achieve High Yields from Clinical to Commercial
Author(s)Catalent
Related Content
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
3
AAPS PharmSci 360: CMC Strategies, Part 1
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5